| Dr Ira D Chatman, MD | |
|
17 Medical Plz, Mountain Home, AR 72653-2918 | |
| (870) 425-6212 | |
| (870) 508-6896 |
| Full Name | Dr Ira D Chatman |
|---|---|
| Gender | Male |
| Speciality | Anesthesiology |
| Experience | 45 Years |
| Location | 17 Medical Plz, Mountain Home, Arkansas |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1922073014 | NPI | - | NPPES |
| 113375001 | Medicaid | AR | |
| 770079401 | Other | AR | BREASTCARE |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207L00000X | Anesthesiology | N7006 (Arkansas) | Secondary |
| 207LP2900X | Anesthesiology - Pain Medicine | N7006 (Arkansas) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Baxter Regional Medical Center | Mountain home, AR | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Interventional Pain Management Associates Pllc | 3779718614 | 8 |
News Archive
A new study aims to identify antibody-based biomarkers associated with the humoral immune response that could be a standard CoP candidate for COVID-19. Further, standardization of research methods to measure these biomarkers has also been conducted.
A new study published in the March 2020 issue of the journal Neurology Clinical Practice reports that smartphone use by people who have headaches is associated with greater use of medication but less relief, compared to those who do not use smartphones when they have headaches. This does not prove that smartphone use is responsible for the increased need for drugs or the relative intractability of the headaches, but shows a linkage.
Autonomic Technologies, Inc. (ATI), the developer of the ATI Neurostimulation System designed for the treatment of severe headaches, today announced results of their clinical study in cluster headache, now published online in Cephalalgia.
A newly-unveiled discovery, which has been four years in the making, has the potential to change the way we look at autoimmune diseases and understand how and why immune cells begin to attack different tissues in the body.
› Verified 6 days ago
| Entity Name | Interventional Pain Management Associates Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1902231178 PECOS PAC ID: 3779718614 Enrollment ID: O20131030000550 |
News Archive
A new study aims to identify antibody-based biomarkers associated with the humoral immune response that could be a standard CoP candidate for COVID-19. Further, standardization of research methods to measure these biomarkers has also been conducted.
A new study published in the March 2020 issue of the journal Neurology Clinical Practice reports that smartphone use by people who have headaches is associated with greater use of medication but less relief, compared to those who do not use smartphones when they have headaches. This does not prove that smartphone use is responsible for the increased need for drugs or the relative intractability of the headaches, but shows a linkage.
Autonomic Technologies, Inc. (ATI), the developer of the ATI Neurostimulation System designed for the treatment of severe headaches, today announced results of their clinical study in cluster headache, now published online in Cephalalgia.
A newly-unveiled discovery, which has been four years in the making, has the potential to change the way we look at autoimmune diseases and understand how and why immune cells begin to attack different tissues in the body.
› Verified 6 days ago
| Entity Name | Baxter County Regional Hospital Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1720430309 PECOS PAC ID: 0042389264 Enrollment ID: O20161201002096 |
News Archive
A new study aims to identify antibody-based biomarkers associated with the humoral immune response that could be a standard CoP candidate for COVID-19. Further, standardization of research methods to measure these biomarkers has also been conducted.
A new study published in the March 2020 issue of the journal Neurology Clinical Practice reports that smartphone use by people who have headaches is associated with greater use of medication but less relief, compared to those who do not use smartphones when they have headaches. This does not prove that smartphone use is responsible for the increased need for drugs or the relative intractability of the headaches, but shows a linkage.
Autonomic Technologies, Inc. (ATI), the developer of the ATI Neurostimulation System designed for the treatment of severe headaches, today announced results of their clinical study in cluster headache, now published online in Cephalalgia.
A newly-unveiled discovery, which has been four years in the making, has the potential to change the way we look at autoimmune diseases and understand how and why immune cells begin to attack different tissues in the body.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Ira D Chatman, MD 17 Medical Plz, Mountain Home, AR 72653-2918 Ph: (870) 425-6212 | Dr Ira D Chatman, MD 17 Medical Plz, Mountain Home, AR 72653-2918 Ph: (870) 425-6212 |
News Archive
A new study aims to identify antibody-based biomarkers associated with the humoral immune response that could be a standard CoP candidate for COVID-19. Further, standardization of research methods to measure these biomarkers has also been conducted.
A new study published in the March 2020 issue of the journal Neurology Clinical Practice reports that smartphone use by people who have headaches is associated with greater use of medication but less relief, compared to those who do not use smartphones when they have headaches. This does not prove that smartphone use is responsible for the increased need for drugs or the relative intractability of the headaches, but shows a linkage.
Autonomic Technologies, Inc. (ATI), the developer of the ATI Neurostimulation System designed for the treatment of severe headaches, today announced results of their clinical study in cluster headache, now published online in Cephalalgia.
A newly-unveiled discovery, which has been four years in the making, has the potential to change the way we look at autoimmune diseases and understand how and why immune cells begin to attack different tissues in the body.
› Verified 6 days ago
James S Clarke, MD Anesthesiology Medicare: Medicare Enrolled Practice Location: 624 Hospital Dr, Mountain Home, AR 72653 Phone: 870-424-1000 | |
Jon R Connelley, MD Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 624 Hospital Drive, Suite 503, Mountain Home, AR 72653 Phone: 870-508-1000 | |
Dr. Matthew James Mcnelley, MD Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 17 Medical Plz, Mountain Home, AR 72653 Phone: 870-508-5900 | |
Dr. William R King, MD Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 624 Hospital Dr, Mountain Home, AR 72653 Phone: 870-424-1000 Fax: 870-424-6616 | |
Mr. Chong H Nicholls, MD Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 624 Hospital Drive, Mountain Home, AR 72653 Phone: 870-508-1000 | |
Charles W Armistead Jr., MD Anesthesiology Medicare: Medicare Enrolled Practice Location: 624 Hospital Dr, Mountain Home, AR 72653 Phone: 870-508-1000 |